Ashland Global Provides Information to Shareholders
January 14, 2019 at 08:19 am EST
Share
On January 14, 2019, Ashland Global Holdings Inc. announced significant changes to the composition and leadership of its board of directors, consistent with its ongoing board refreshment program. The Company stated that these include the addition of 2 new independent board members: Craig A. Rogerson and Michael J. Ward, appointment of a lead independent director and appointment of new board committee chairs. The Company stated that Neuberger Berman assisting in process and voting for the Company slate of nominees for 2019 annual meeting. The Company also stated that it has initiated search for 2 new directors in consultation with Neuberger Berman and with input from other shareholders. The Company also recommended its shareholders to vote on the Company’s proxy card for all 11 of its director nominees: Brendan M. Cummins, William G. Dempsey, Jay V. Ihlenfeld, Susan L. Main, Jerome A. Peribere, Craig A. Rogerson, Mark C. Rohr, Janice J. Teal, Michael J. Ward, Kathleen Wilson-Thompson and William A. Wulfsohn.
Ashland Inc. is a global specialty additives and materials company. The Company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The Company's segments include life sciences, personal care, specialty additives and intermediates. The life sciences segment is comprised of pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films and fine chemicals. The personal care segment is comprised of bio functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The specialty additives segment is comprised of rheology and additives serving the architectural coatings, construction, energy, automotive and various industrial markets. Its Intermediates segment is comprised of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.